<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03764202</url>
  </required_header>
  <id_info>
    <org_study_id>WUWQNXM 2015-1-36</org_study_id>
    <nct_id>NCT03764202</nct_id>
  </id_info>
  <brief_title>Determination of Sufentanil in Breast Milk of Puerpera</brief_title>
  <official_title>Determination of Sufentanil in Breast Milk of Puerpera During Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujian Medical University Union Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujian Medical University Union Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determination of sufentanil in human breast milk during the administration of the&#xD;
      sufentanil via the analgesic infusion pump and after the administration, to determine whether&#xD;
      the breastfeeding after clinical anesthetic or analgesic administration has an effect on the&#xD;
      infant and provide a reference for the security issues.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The concentration of sufentanil in milk was determined by LC-MS /MS method( liquid&#xD;
      chromatography mass spectrometry).The separation was carried on Agilent ZORBAX Eclipse Plus&#xD;
      C18 column(2.1×50 mm, 3.5 μm)with a mobile phase of 10 mmol ammonium formate(A)and&#xD;
      methanol(B), and the elution conditions were optimized as follows：linear gradient 0→0.30 min,&#xD;
      A:B=50:50; 0.30→0.31 min, A:B=50:50→10:90; 3.00→3.10 min, A:B=10:90→50:50; 3.1→6.5min,&#xD;
      A:B=50:50; The flowing rate was 0.2 mL•min-1, column temperature was 30 ℃, injection volume&#xD;
      was 5 μL. ESI source was applied and operated in positive ion mode. Quantitative&#xD;
      determination was performed using multiple reaction monitoring (MRM) of m/z 387.2 → m/z 238.2&#xD;
      for sufentanil, and m/z 337.2 → m/z 158.2 for fentanyl.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The concentration of sufentanil in human breast milk</measure>
    <time_frame>1 year</time_frame>
    <description>The concentration of sufentanil in human breast milk was detected at each fixed time point</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The volume of human breast milk</measure>
    <time_frame>1 year</time_frame>
    <description>The volume of human breast milk was detected at each fixed time point</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The dose of sufentanil in human breast milk</measure>
    <time_frame>1 year</time_frame>
    <description>The amount of sufentanil in the milk multiplied by the concentration of sufentanil and the volume of milk at each fixed time point</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>CSEA，1μg/kg•d</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The puerpera received combined spinal epidural anesthesia&#xD;
The dosage of sufentanil intravenous analgesia was 1 μg/kg•d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CSEA，1.5μg/kg•d</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The puerpera received combined spinal epidural anesthesia&#xD;
The dosage of sufentanil intravenous analgesia was 1.5 μg/kg•d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GA，1μg/kg•d</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The puerpera received general anesthesia&#xD;
The dosage of sufentanil intravenous analgesia was 1 μg/kg•d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GA，1.5μg/kg•d</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The puerpera received general anesthesia&#xD;
The dosage of sufentanil intravenous analgesia was 1.5 μg/kg•d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CSEA，Epidural analgesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The puerpera received combined spinal epidural anesthesia&#xD;
Postoperative analgesia was performed with epidural analgesia&#xD;
Speed of epidural analgesia pump ：6ml/h（0.1% ropivacaine , 0.5μg/ml sufentanil）</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Detection of sufentanil concentration</intervention_name>
    <description>Concentration of sufentanil in human breast milk was determined by LC-MS /MS method&#xD;
The volume of human breast milk was detected at each fixed time point</description>
    <arm_group_label>CSEA，1.5μg/kg•d</arm_group_label>
    <arm_group_label>CSEA，1μg/kg•d</arm_group_label>
    <arm_group_label>CSEA，Epidural analgesia</arm_group_label>
    <arm_group_label>GA，1.5μg/kg•d</arm_group_label>
    <arm_group_label>GA，1μg/kg•d</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 20yr to 38yr&#xD;
&#xD;
          -  Height 155~170 cm&#xD;
&#xD;
          -  Weight 65~85 Kg&#xD;
&#xD;
          -  American Society of Anesthesiologists statuses I or II&#xD;
&#xD;
          -  Normal cardiac and pulmonary function&#xD;
&#xD;
          -  Undergoing elective Cesarean section&#xD;
&#xD;
          -  Willing to provide breast milk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy induced hypertension&#xD;
&#xD;
          -  gestational diabetes&#xD;
&#xD;
          -  gestational heart disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhang liangcheng, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fujian Medical University Union Hospital</affiliation>
  </overall_official>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 25, 2018</study_first_submitted>
  <study_first_submitted_qc>December 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2018</study_first_posted>
  <last_update_submitted>December 2, 2018</last_update_submitted>
  <last_update_submitted_qc>December 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

